Dr. Azka Bilal is a Austin, Texas based psychiatrist who is specialized in Child & Adolescent. Active license number of Dr. Azka Bilal is S0430 for Child & Adolescent in Texas. Her current practice location is 4110 Guadalupe St, Austin. Patients can reach her at 512-452-0381. Dr. Azka Bilal is MD in Child & Adolescent and her NPI number (Unique professional ID assigned by NPPES) is 1881003077. Dr. Azka Bilal has done additional skills and training in the diagnosis and treatment of developmental, behavioral, emotional, and mental disorders of childhood and adolescence.
Complete Profile:
Dr. Azka Bilal speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Dr. Azka Bilal
Specialization:
Child & Adolescent
Gender:
Female
Credentials:
MD
Practice Address:
4110 Guadalupe St, Austin, Texas, 78751-4223
Phone:
512-452-0381
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1881003077
NPI Enumeration Date:
12 Aug, 2014
NPI Last Update On:
23 Apr, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Azka Bilal are as mentioned below.
License Number
Specialization
State
Status
S0430
Child & Adolescent
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Azka Bilal 4110 Guadalupe St, Austin, Texas
Zip:
78751-4223
Patients can reach Dr. Azka Bilal at 4110 Guadalupe St, Austin, Texas or can call to book an appointment on 512-452-0381.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.